Opening Paragraph:
According to a new report by Maximize Market Research, the global Age-Related Macular Degeneration (AMD) Market was valued at USD 10.52 billion in 2023 and is projected to reach USD 11.25 billion by 2030, growing at a CAGR of 6.9%. Market growth is fueled by the increasing elderly population, rising prevalence of AMD, and ongoing innovations in therapies and diagnostics across North America, Europe, and Asia Pacific.

Key Highlights:

• Market Size & CAGR: USD 10.52 Bn in 2023, expected to reach USD 11.25 Bn by 2030 at 6.9% CAGR.
• Leading Segment: Dry AMD, representing approximately 85–90% of cases.
• Fastest-Growing/Largest Region: North America dominates due to robust healthcare infrastructure and high patient awareness.
• Key Drivers & Trends: Aging population, advanced diagnostics (OCT, genetic testing), gene therapy, stem cell research, and anti-VEGF therapeutics.
• Top Companies: Regeneron Pharmaceuticals, Allergan, Genentech, Apellis Pharmaceuticals, Novartis, Roche, Kubota Vision, Santen Pharmaceutical.

Want to know more? Request your sample report today : https://www.maximizemarketresearch.com/request-sample/36109/ 

Market Outlook

The AMD market is categorized by disease type into Dry AMD and Wet AMD. Dry AMD holds the largest share due to its high prevalence and lack of approved therapies, driving research and development. Wet AMD, while less prevalent, requires ongoing treatment with anti-VEGF therapies and innovative delivery solutions. Advances in gene therapy, stem cell approaches, and bioelectronic implants are creating new growth avenues in both segments.

Regional Insights

North America leads the AMD market, supported by advanced healthcare systems, sophisticated diagnostics, and a growing elderly population. Europe follows with strong research capabilities and established pharmaceutical infrastructure. Asia Pacific presents significant growth opportunities as healthcare access expands and awareness increases. Emerging markets in South America and the Middle East & Africa show potential due to rising healthcare investment and aging populations.

Gain more details with a free sample report. Inquire now : https://www.maximizemarketresearch.com/request-sample/36109/ 

Key Players

Major players driving the market include Regeneron Pharmaceuticals, Allergan, Genentech, Apellis Pharmaceuticals, and Novartis in North America and Europe. Asia Pacific’s notable contributors include Kubota Vision (Japan) and Santen Pharmaceutical (Japan). Companies are focusing on gene therapies, oral therapeutics, and advanced drug delivery platforms to address unmet needs, enhance patient outcomes, and strengthen market presence.

Quote:
With the aging global population and ongoing innovations in AMD diagnostics and therapies, the market is poised for sustained growth, offering opportunities to improve patient outcomes while expanding treatment accessibility,” said a senior analyst at Maximize Market Research.

About Maximize Market Research
Maximize Market Research is a global market intelligence company providing syndicated and customized research reports across industries, enabling clients to make informed business decisions. For more information, visit www.maximizemarketresearch.com